Albert David Limited (BOM:524075)
756.35
+29.40 (4.04%)
At close: May 5, 2026
Albert David Market Cap
Albert David has a market cap or net worth of 4.6 billion as of May 6, 2026. Its market cap has increased by 4.48% in one year.
Market Cap
4.60B
Enterprise Value
2.17B
Revenue
3.23B
Ranking
n/a
PE Ratio
47.87
Stock Price
756.35
Market Cap Chart
Since October 30, 2001, Albert David's market cap has increased from 80.47M to 4.60B, an increase of 5,618.09%. That is a compound annual growth rate of 17.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 4.32B | 2.21% |
| Dec 31, 2025 | 4.22B | -44.14% |
| Dec 31, 2024 | 7.56B | 35.71% |
| Dec 29, 2023 | 5.57B | 71.95% |
| Dec 30, 2022 | 3.24B | -6.10% |
| Dec 31, 2021 | 3.45B | 36.82% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kilitch Drugs (India) | 5.36B |
| Amanta Healthcare | 4.82B |
| ZIM Laboratories | 4.71B |
| Jenburkt Pharmaceuticals | 4.61B |
| Medico Remedies | 3.53B |
| Medicamen Biotech | 3.29B |
| Sat Kartar Life | 3.08B |
| Trident Lifeline | 2.98B |